D
Achieve Life Sciences, Inc. ACHV
$4.95 $0.173.56% NASDAQ
Recommendation
Prev Close
$4.78
Volume
900,588
Avg Vol (90D)
1,543,823
Market Cap
$244.28M
Dividend & Yield
--
52-Week Range
$1.84 - $5.78
P/E (TTM)
--
EPS (TTM)
-$1.46
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and ...
10/29/2025 - GuruFocus
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
10/29/2025 - Globe Newswire
Achieve Life Sciences (ACHV, $4.68) RSI Indicator left the overbought zone on October 27, 2025
10/28/2025 - Tickeron - Stocks
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above 200 Day Moving Average - What's Next?
10/28/2025 - MarketBeat
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
10/22/2025 - Insider Monkey
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
10/20/2025 - GuruFocus
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), BeOne Medicines (ONC)
10/20/2025 - TipRanks Financial Blog
Achieve Life Sciences appoints Atkisson as Chief Legal Officer
10/20/2025 - TipRanks Financial Blog
Achieve Life Sciences appoints Atkisson as Chief Legal Officer
10/20/2025 - The Fly
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
10/20/2025 - Globe Newswire
FDA Grants First CNPV Vouchers, Igniting Rally in Biotech Stocks
10/20/2025 - GuruFocus
Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Awards Rare Priority Voucher for Vaping Cessation Drug Has the Bull Case Changed?
10/20/2025 - Simply Wall St
A Look at Achieve Life Sciences's Valuation After Rare FDA Priority Voucher for Nicotine Vaping Therapy
10/18/2025 - Simply Wall St
Stock Traders Purchase High Volume of Call Options on Achieve Life Sciences (NASDAQ:ACHV)
10/18/2025 - MarketBeat
Achieve Life Sciences (ACHV, $4.2) RSI Indicator left the overbought zone on October 17, 2025
10/18/2025 - Tickeron - Stocks
Achieve Life Sciences (ACHV, $4.2) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 17, 2025
10/18/2025 - Tickeron - Stocks
Achieve Life Sciences (ACHV) Gets a Buy from Raymond James
10/18/2025 - TipRanks Financial Blog
Achieve Life Sciences Stock Soars On Receiving FDA Voucher For Expediting Review Of Investigational Drug In Vaping Cessation
10/17/2025 - Stocktwits News Feed
Achieve Life Sciences (ACHV) Surges Amid FDA Priority Review Voucher Award
10/17/2025 - GuruFocus
Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline ...
10/17/2025 - GuruFocus
Achieve Life Sciences receives FDA CNPV for cytisinicline
10/17/2025 - TipRanks Financial Blog
Achieve Life Sciences receives FDA CNPV for cytisinicline
10/17/2025 - The Fly
Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation
10/17/2025 - Globe Newswire
Achieve Life Sciences (ACHV, $3.08) entered Downtrend as Momentum indicator drops below 0 level on Oct 16, 2025
10/17/2025 - Tickeron - Technical Analysis
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average - Here's What Happened
10/15/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$49.88M
EBIT (TTM)
-$50.11M
Net Income (TTM)
-$50.42M
Balance Sheet
Total Assets (Q)
$58.94M
Total Debt (Q)
$9.96M
Total Liabilities (Q)
$17.27M
Book Value Per Share (Q)
$0.8386
Cash Flow
Cash from Operations (TTM)
-$39.72M
Cash from Investing (TTM)
$43.04M
Cash from Financing (TTM)
$33.79M
Net Change in Cash (TTM)
$37.12M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
0.99
7-Day Total Return
-1.00%
30-Day Total Return
67.23%
60-Day Total Return
88.93%
90-Day Total Return
28.91%
Year to Date Total Return
34.15%
1-Year Total Return
4.87%
2-Year Total Return
24.37%
3-Year Total Return
123.98%
5-Year Total Return
-39.41%
52-week Low
Apr 09, 2025 - $1.84
52-week High
Oct 21, 2025 - $5.78
Valuation
Market Cap
$244.28M - Micro Cap
Enterprise Value
$198.84M
Price/Sales (TTM)
--
Price/Book (Q)
5.70
Dividends and Shares
Shares Outstanding
34.69
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.achievelifesciences.com
Phone Number
604 210 2217
Address
22722 29th Dr. SE
Bothell, WA 98021
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The... more
NASDAQ 10/29/2025 4:00PM Eastern Quotes delayed